Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Clinical trial NCT07549906 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07549906
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colon Cancer (Stage II &Amp; III)Immunotherapy Beta Blocker Neoadjuvant Chemoimmunotherapy

Start date: 2026-04-20
Primary completion: 2026-07-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.